arrow
B

Benjamin A. Gartrell

Albert Einstein College of Medicine
H指数:32
被引数:4,293

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nivolumab and Cabozantinib in People with HIV and Advanced Solid Tumors: A Pilot Trial and Systematic Review

纳武利尤单抗和卡博替尼在HIV感染者及晚期实体瘤患者中的应用:一项初步试验和系统综述

2026-10-080
OA
An intra-patient contemporaneous comparison of 18F-piflufolastat and 18F-flotufolastat urinary radioactivity and pelvic region detection rates in men with low PSA biochemical recurrence of prostate cancer after radical prostatectomy

同一患者同时期比较18F-piflufolastat和18F-flotufolastat的尿液放射性及盆腔区域检出率,对象为接受根治性前列腺切除术后出现低PSA生化复发的男性前列腺癌患者。

2026-02-230
OAAI
Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial

前列腺癌生命质量的遗传驱动因素:对E3805 CHAARTED试验中遗传多态性和患者报告结局的评估

2025-04-160
PRE
Influential Factors Impacting Treatment Decision-making and Decision Regret in Patients with Localized or Locally Advanced Prostate Cancer: A Systematic Literature Review

影响局部或局部晚期前列腺癌患者治疗决策和决策后悔的影响因素: 系统文献综述

2024-12-010
OA
PrECOG PrE0807: A Phase 1b Feasibility Trial of Neoadjuvant Nivolumab Without and with Lirilumab in Patients with Muscle-invasive Bladder Cancer Ineligible for or Refusing Cisplatin-based Neoadjuvant Chemotherapy
2024-08-015
PRE
Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma
2024-05-300
OAAI
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN
2023-11-114
OAAI
A phase Ib single-arm trial of bintrafusp alfa (BA) for pretreated, locally advanced/unresectable or metastatic (advanced) urothelial cancer (aUC)
2023-10-010
OA
Reply by Authors
2023-08-010
PRE
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)

18F-rhPSMA-7.3正电子发射断层扫描在疑似前列腺癌复发男性中的诊断性能和安全性: 来自3期,前瞻性,多中心研究 (SPOTLIGHT) 的结果

2023-08-0136
OA
A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guerin in Patients with High-risk Non- muscle-invasive Bladder Cancer

阿特珠单抗联合或不联合卡介苗治疗高危非肌层浸润性膀胱癌患者的1b/2期研究

2023-06-0113
OA
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer
2022-05-127
OAAI
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer
2021-10-254
OA
Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer

功能性琥珀酸脱氢酶缺乏症是透明细胞肾癌的常见不良特征

2021-09-2239
OAAI
Gene expression profiling (GEP) signatures associated with markers of sensitivity to immune and angiogenic therapy in clear-cell renal cell carcinoma (ccRCC) with sarcomatoid/rhabdoid features
2021-09-011
OAAI